JNJ · News · 20261030N

Revenue Performance and Mix

JOHNSON & JOHNSON · 2026-10-30 · Importance 43 · Surprise 32

Johnson & Johnson reported 6.1% organic sales growth in Q3. Sales growth slowed for two consecutive quarters, according to Trefis. The report said newer medicines such as TREMFYA contributed to growth in Innovative Medicine.

Key facts